Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043804591> ?p ?o ?g. }
- W3043804591 endingPage "108479" @default.
- W3043804591 startingPage "108479" @default.
- W3043804591 abstract "The upregulation of checkpoint inhibitor PD-L1 expression has recently been associated with nasopharyngeal carcinoma (NPC) resistance to therapy. The mechanism of induction of PD-L1 has also been linked to enhanced aerobic glycolysis promoted by HIF1-α dysregulation and LDH-A activity in cancer. Here, we investigated the effect of the anti-tumoral compound Silibinin on HIF-1α/LDH-A mediated cancer cell metabolism and PD-L1 expression in NPC. Our results demonstrate that exposure to Silibinin potently inhibits tumor growth and promotes a shift from aerobic glycolysis toward oxidative phosphorylation. The EBV + NPC cell line C666-1 and glycolytic human tumor explants treated with Silibinin displayed a reduction in LDH-A activity which consistently associated with a reduction in lactate levels. This effect was accompanied by an increase in intracellular citrate levels in C666-1 cells. Accordingly, expression of HIF-1α, a critical regulator of glycolysis, was down-regulated after treatment. This event associated with a down-regulation in PD-L1. Altogether, our results provide evidence that silibinin can alter PD-L1 expression by interfering with HIF-1α/LDH-A mediated cell metabolism in NPC. These results provide a new perspective for Silibinin use to overcome PD-L1 mediated NPC resistance to therapy." @default.
- W3043804591 created "2020-07-23" @default.
- W3043804591 creator A5002951130 @default.
- W3043804591 creator A5032268246 @default.
- W3043804591 creator A5042109271 @default.
- W3043804591 creator A5051222086 @default.
- W3043804591 creator A5057942915 @default.
- W3043804591 creator A5060280764 @default.
- W3043804591 creator A5069425402 @default.
- W3043804591 creator A5079066496 @default.
- W3043804591 creator A5085557698 @default.
- W3043804591 creator A5088096428 @default.
- W3043804591 date "2020-09-01" @default.
- W3043804591 modified "2023-09-26" @default.
- W3043804591 title "Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism" @default.
- W3043804591 cites W1480881123 @default.
- W3043804591 cites W1851711468 @default.
- W3043804591 cites W1965748088 @default.
- W3043804591 cites W1969762178 @default.
- W3043804591 cites W1972944556 @default.
- W3043804591 cites W1973092951 @default.
- W3043804591 cites W2001151803 @default.
- W3043804591 cites W2005170435 @default.
- W3043804591 cites W2008854828 @default.
- W3043804591 cites W2010861323 @default.
- W3043804591 cites W2019419382 @default.
- W3043804591 cites W2031391029 @default.
- W3043804591 cites W2033254113 @default.
- W3043804591 cites W2038009564 @default.
- W3043804591 cites W2039116587 @default.
- W3043804591 cites W2058218780 @default.
- W3043804591 cites W2059775855 @default.
- W3043804591 cites W2060628991 @default.
- W3043804591 cites W2064171983 @default.
- W3043804591 cites W2085609942 @default.
- W3043804591 cites W2089716357 @default.
- W3043804591 cites W2098249288 @default.
- W3043804591 cites W2104350866 @default.
- W3043804591 cites W2110185005 @default.
- W3043804591 cites W2111140446 @default.
- W3043804591 cites W2116508433 @default.
- W3043804591 cites W2133128767 @default.
- W3043804591 cites W2144825354 @default.
- W3043804591 cites W2149360266 @default.
- W3043804591 cites W2150434794 @default.
- W3043804591 cites W2163471981 @default.
- W3043804591 cites W2218851706 @default.
- W3043804591 cites W2234115940 @default.
- W3043804591 cites W2306090029 @default.
- W3043804591 cites W2508195907 @default.
- W3043804591 cites W2515779177 @default.
- W3043804591 cites W2521748409 @default.
- W3043804591 cites W2529484692 @default.
- W3043804591 cites W2534390269 @default.
- W3043804591 cites W2563749186 @default.
- W3043804591 cites W2566780377 @default.
- W3043804591 cites W2588574345 @default.
- W3043804591 cites W2594001971 @default.
- W3043804591 cites W2602922057 @default.
- W3043804591 cites W2625416742 @default.
- W3043804591 cites W2711613673 @default.
- W3043804591 cites W2730966137 @default.
- W3043804591 cites W2734897379 @default.
- W3043804591 cites W2737971561 @default.
- W3043804591 cites W2747272999 @default.
- W3043804591 cites W2887249435 @default.
- W3043804591 cites W2892740414 @default.
- W3043804591 cites W2900534583 @default.
- W3043804591 cites W2921217908 @default.
- W3043804591 cites W2955283109 @default.
- W3043804591 cites W2958648554 @default.
- W3043804591 doi "https://doi.org/10.1016/j.abb.2020.108479" @default.
- W3043804591 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8507490" @default.
- W3043804591 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32679194" @default.
- W3043804591 hasPublicationYear "2020" @default.
- W3043804591 type Work @default.
- W3043804591 sameAs 3043804591 @default.
- W3043804591 citedByCount "25" @default.
- W3043804591 countsByYear W30438045912020 @default.
- W3043804591 countsByYear W30438045912021 @default.
- W3043804591 countsByYear W30438045912022 @default.
- W3043804591 countsByYear W30438045912023 @default.
- W3043804591 crossrefType "journal-article" @default.
- W3043804591 hasAuthorship W3043804591A5002951130 @default.
- W3043804591 hasAuthorship W3043804591A5032268246 @default.
- W3043804591 hasAuthorship W3043804591A5042109271 @default.
- W3043804591 hasAuthorship W3043804591A5051222086 @default.
- W3043804591 hasAuthorship W3043804591A5057942915 @default.
- W3043804591 hasAuthorship W3043804591A5060280764 @default.
- W3043804591 hasAuthorship W3043804591A5069425402 @default.
- W3043804591 hasAuthorship W3043804591A5079066496 @default.
- W3043804591 hasAuthorship W3043804591A5085557698 @default.
- W3043804591 hasAuthorship W3043804591A5088096428 @default.
- W3043804591 hasBestOaLocation W30438045912 @default.
- W3043804591 hasConcept C104317684 @default.
- W3043804591 hasConcept C109156525 @default.
- W3043804591 hasConcept C126322002 @default.
- W3043804591 hasConcept C127561419 @default.